In This Section

Newsroom

April 30, 2020
Temple Scientists Regenerate Neurons in Mice with Spinal Cord Injury and Optic Nerve Damage

In a study published online in the journal Molecular Therapy, Temple researchers describe the ability of a molecule known as Lin28 – when expressed above its usual levels – can fuel axon regrowth in mice with spinal cord injury or optic nerve injury, enabling repair of the body's communication grid.
- VIEW STORY
April 29, 2020
Temple Now Offering a Variety of Clinical Trials and Investigational Treatment Options for Patients with COVID-19

Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with COVID-19.
- VIEW STORY
April 23, 2020
Temple Researchers Show Protein Produced By Heart in Sepsis Lowers Blood Pressure, Identify Treatment to Reverse its Effects

In a new study, scientists at the Lewis Katz School of Medicine show that when a molecule known as c-Jun N-terminal kinase (JNK) becomes active in sepsis, it increases the production of a protein called B-type natriuretic peptide (BNP) – the more BNP that is produced in sepsis, the greater the deterioration of cardiovascular function.
- VIEW STORY
April 16, 2020
Temple Students Are Doing Their Part

During this global pandemic and uncertain time, students at the Lewis Katz School of Medicine are finding ways to work together and with the community to do their part wherever they can.
- VIEW STORY
April 16, 2020
Temple Healthcare Workers Called To Join National PCORnet® Study To Fight COVID-19 Together

HeroesResearch.org clinical research registry launches to answer crucial questions about the impact of novel coronavirus on healthcare workers' lives and provides framework and first step for Temple University Health System healthcare workers to join clinical trial.
- VIEW STORY
April 15, 2020
Temple Treats First Patient in the U.S. in Clinical Trial of Gimsilumab for Patients with COVID-19 and Acute Respiratory Distress Syndrome

Temple University Hospital has treated the first patient in the US in the BREATHE clinical trial evaluating the impact of IV treatment with gimsilumab on mortality for patients with COVID-19 and ARDS.
- VIEW STORY
April 14, 2020
Temple Researchers Awarded $1.98 Million from NIAID to Investigate T-Cell Activation

Scientists at the Lewis Katz School of Medicine are poised to make major headway into the study of immunological synapse formation through a new $1.98M grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases.
- VIEW STORY
April 13, 2020
Students Scour the Region to Help Bridge PPE Gap at Temple

Over the past few weeks, Temple students have scoured the Philadelphia region for personal protective equipment and cleaning supplies and delivered their finds to the Temple Emergency Department by the carload. Their ingenuity has led to some surprising donors.
- VIEW STORY

Newsroom

Pages